NASDAQ:MNKD - Nasdaq - US56400P7069 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to MNKD. MNKD was compared to 567 industry peers in the Biotechnology industry. MNKD has an average financial health and profitability rating. MNKD is not priced too expensively while it is growing strongly. Keep and eye on this one!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7% | ||
ROE | N/A | ||
ROIC | 20.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 25.07% | ||
PM (TTM) | 9.66% | ||
GM | 74.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 8.83 | ||
Altman-Z | -7.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.28 | ||
Quick Ratio | 2.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.25 | ||
Fwd PE | 25.41 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 43.89 | ||
EV/EBITDA | 17.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
4.74
+0.07 (+1.5%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.25 | ||
Fwd PE | 25.41 | ||
P/S | 5.04 | ||
P/FCF | 43.89 | ||
P/OCF | 33.88 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 17.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7% | ||
ROE | N/A | ||
ROCE | 22.94% | ||
ROIC | 20.74% | ||
ROICexc | 56.39% | ||
ROICexgc | 60.16% | ||
OM | 25.07% | ||
PM (TTM) | 9.66% | ||
GM | 74.19% | ||
FCFM | 11.49% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 8.83 | ||
Debt/EBITDA | 3.39 | ||
Cap/Depr | 131.5% | ||
Cap/Sales | 3.4% | ||
Interest Coverage | 4.09 | ||
Cash Conversion | 53.84% | ||
Profit Quality | 118.96% | ||
Current Ratio | 3.28 | ||
Quick Ratio | 2.94 | ||
Altman-Z | -7.66 |